Climb Bio files lawsuit against Alumis over drug asset dispute

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. GTLB
2. DELL
3. PANW
4. MDB
5. CRDO
6. MMED
7. CL
8. VRT
9. GPUS
10. SGLD

Go back to Climb Bio files lawsuit against Alumis over drug asset dispute
(NASDAQ: CLYM) Delayed: 14.82 --0 (-0%)
Previous Close $14.82    52 Week High $ 
Open $14.82    52 Week Low $ 
Day High $14.82    P/E N/A 
Day Low $14.82    EPS $ 
Volume 3,606